{"filing":{"accession_number":"0001493152-26-036740","cik":"0001430306","ticker":"TNXP","company_name":"Tonix Pharmaceuticals Holding Corp.","form":"8-K","filing_date":"2026-08-10","report_date":"2026-08-10","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1430306/000149315226036740/form8-k.htm"},"events":[{"id":26353,"run_id":23944,"accession_number":"0001493152-26-036740","anchor_item_number":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The 8-K discloses Tonix Pharmaceuticals' second quarter 2026 financial results under Item 2.02 (Results of Operations and Financial Condition). The press release reports Q2 2026 net product revenue of $13.5 million (vs. $2.0 million in Q2 2025), with TONMYA net sales of $11.0 million representing 197% quarter-over-quarter growth. The filing includes detailed financial metrics, operational highlights, and cash position ($176.2 million as of June 30, 2026), which are material to investors assessing the company's commercial execution and financial trajectory.","company_name":"Tonix Pharmaceuticals Holding Corp.","ticker":"TNXP","filing_date":"2026-08-10","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":27445,"accession_number":"0001493152-26-036740","item_number":null,"item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The 8-K discloses Tonix Pharmaceuticals' second quarter 2026 financial results under Item 2.02 (Results of Operations and Financial Condition). The press release reports Q2 2026 net product revenue of $13.5 million (vs. $2.0 million in Q2 2025), with TONMYA net sales of $11.0 million representing 197% quarter-over-quarter growth. The filing includes detailed financial metrics, operational highlights, and cash position ($176.2 million as of June 30, 2026), which are material to investors assessing the company's commercial execution and financial trajectory.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T11:17:05.312054+00:00","company_name":"Tonix Pharmaceuticals Holding Corp.","ticker":"TNXP","filing_date":"2026-08-10"}]}